Accelerating nanodrug development in continuous flow systems using informed prediction models based on low-cost surrogate nanoparticles
DGX agentarXiv:2608.05761v1 Announce Type: new Abstract: The development of nanotherapeutics often involves extensive empirical optimization due to the sensitivity of nanoparticle properties, such as size and